Codiak BioSciences, Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Codiak BioSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2022.
  • Codiak BioSciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$21.4M, a 0.47% increase year-over-year.
  • Codiak BioSciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$53.3M, a 24.4% increase year-over-year.
  • Codiak BioSciences, Inc. annual Operating Income (Loss) for 2021 was -$69.5M, a 23.5% increase from 2020.
  • Codiak BioSciences, Inc. annual Operating Income (Loss) for 2020 was -$90.9M, a 13.4% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$53.3M -$21.4M +$100K +0.47% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$53.4M -$7.02M +$14.4M +67.3% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$67.9M -$8.25M +$1.7M +17.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$69.5M -$16.6M +$967K +5.49% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-10
Q3 2021 -$70.5M -$21.5M +$13.5M +38.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$84M -$21.5M -$5.67M -35.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$78.4M -$9.95M +$12.5M +55.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$90.9M -$17.6M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$35M -$13.8M -65% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$15.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$22.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 -$21.2M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.